The Need for Predictive, Prognostic, Objective and Complementary Blood-Based Biomarkers in Osteoarthritis (OA)

被引：24

作者：

Bay-Jensen, Anne-C ^{[1
]}

Henrotin, Yves ^{[2
,3
]}

Karsdal, Morten ^{[1
,4
]}

Mobasheri, Ali ^{[5
,6
,7
,8
,9
,10
]}

机构：

[1] Nord Biosci, Rheumatol Biomarkers & Res, Herlev, Denmark

[2] Univ Liege, Bone & Cartilage Res Unit, Arthropole Liege, Liege, Belgium

[3] Princess Paola Hosp, Phys Therapy & Rehabil Dept, Marche En Famenne, Belgium

[4] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England

[5] Univ Southern Denmark, Dept Canc & Inflammat Res, Copenhagen, Denmark

[6] Queens Med Ctr, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Nottingham NG7 2UH, England

[7] King Abdulaziz Univ, CEGMR, KFMRC, Jeddah 21413, Saudi Arabia

[8] Queens Med Ctr, Arthrit Res UK Pain Ctr, Nottingham NG7 2UH, England

[9] Queens Med Ctr, MRC, Nottingham NG7 2UH, England

[10] Queens Med Ctr, Arthrit Res UK Ctr Musculoskeletal Ageing Res, Nottingham NG7 2UH, England

来源：

EBIOMEDICINE | 2016年 / 7卷

关键词：

D O I：

10.1016/j.ebiom.2016.05.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4 / 6

页数：3

共 9 条

[1] Classification of osteoarthritis biomarkers:: a proposed approach [J].

Bauer, D. C. ;

Hunter, D. J. ;

Abramson, S. B. ;

Attur, M. ;

Corr, M. ;

Felson, D. ;

Heinegard, D. ;

Jordan, J. M. ;

Kepler, T. B. ;

Lane, N. E. ;

Saxne, T. ;

Tyree, B. ;

Kraus, V. B. .

OSTEOARTHRITIS AND CARTILAGE, 2006, 14 (08) :723-727

[2] Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria [J].

Bay-Jensen, A. C. ;

Reker, D. ;

Kjelgaard-Petersen, C. F. ;

Mobasheri, A. ;

Karsdal, M. A. ;

Ladel, C. ;

Henrotin, Y. ;

Thudium, C. S. .

OSTEOARTHRITIS AND CARTILAGE, 2016, 24 (01) :9-20

[3] Parallel evolution of OA phenotypes and therapies [J].

Conaghan, Philip G. .

NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (02) :68-70

[4]

Karsdal M. A., 2013, OSTEOARTHR CARTIL

[5] Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis [J].

Kraus, V. B. ;

Burnett, B. ;

Coindreau, J. ;

Cottrell, S. ;

Eyre, D. ;

Gendreau, M. ;

Gardiner, J. ;

Garnero, P. ;

Hardin, J. ;

Henrotin, Y. ;

Heinegard, D. ;

Ko, A. ;

Lohmander, L. S. ;

Matthews, G. ;

Menetski, J. ;

Moskowitz, R. ;

Persiani, S. ;

Poole, A. R. ;

Rousseau, J. -C. ;

Todman, M. .

OSTEOARTHRITIS AND CARTILAGE, 2011, 19 (05) :515-542

[6]

Kraus V. B., 2015, OSTEOARTHR CARTIL

[7] The Future of Osteoarthritis Therapeutics: Targeted Pharmacological Therapy [J].

Mobasheri, A. .

CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (10)

[8]

Patterson SD, 2011, PHARMACOGENOMICS, V12, P939, DOI [10.2217/pgs.11.52, 10.2217/PGS.11.52]

[9] The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon? [J].

Qvist, Per ;

Bay-Jensen, Anne-Christine ;

Christiansen, Claus ;

Dam, Erik B. ;

Pastoureau, Philippe ;

Karsdal, Morten A. .

PHARMACOLOGICAL RESEARCH, 2008, 58 (01) :1-7

← 1 →